Abbott Laboratories (BVMF:ABTT34)
Brazil · Delayed Price · Currency is BRL 59.40
+0.13 (0.22%)
Last updated: Oct 7, 2025, 12:43 PM GMT-3
Abbott Laboratories Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| 43,109 | 41,950 | 40,109 | 43,653 | 43,075 | 34,608 | Upgrade | |
Revenue Growth (YoY) | 5.85% | 4.59% | -8.12% | 1.34% | 24.46% | 8.48% | Upgrade |
Cost of Revenue | 20,737 | 20,584 | 19,941 | 21,155 | 20,584 | 17,135 | Upgrade |
Gross Profit | 22,372 | 21,366 | 20,168 | 22,498 | 22,491 | 17,473 | Upgrade |
Selling, General & Admin | 11,954 | 11,697 | 10,949 | 11,248 | 11,324 | 9,696 | Upgrade |
Research & Development | 2,903 | 2,844 | 2,741 | 2,888 | 2,742 | 2,420 | Upgrade |
Operating Income | 7,515 | 6,825 | 6,478 | 8,362 | 8,425 | 5,357 | Upgrade |
Interest Income | - | 344 | 385 | 183 | 43 | 46 | Upgrade |
Interest Expense | -530 | -559 | -637 | -558 | -533 | -546 | Upgrade |
Other Non-Operating Income (Expense) | 578 | 403 | 438 | 319 | 276 | 111 | Upgrade |
Total Non-Operating Income (Expense) | 48 | 188 | 186 | -56 | -214 | -389 | Upgrade |
Pretax Income | 7,898 | 7,013 | 6,664 | 8,306 | 8,211 | 4,968 | Upgrade |
Provision for Income Taxes | -6,081 | -6,389 | 941 | 1,373 | 1,140 | 497 | Upgrade |
Net Income | 13,979 | 13,402 | 5,723 | 6,933 | 7,071 | 4,495 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | - | 24 | Upgrade |
Net Income to Common | 13,979 | 13,402 | 5,723 | 6,933 | 7,071 | 4,495 | Upgrade |
Net Income Growth | 151.56% | 134.18% | -17.45% | -1.95% | 57.31% | 21.92% | Upgrade |
Shares Outstanding (Basic) | 1,740 | 1,740 | 1,740 | 1,753 | 1,775 | 1,773 | Upgrade |
Shares Outstanding (Diluted) | 1,747 | 1,748 | 1,749 | 1,764 | 1,789 | 1,786 | Upgrade |
Shares Change (YoY) | -0.08% | -0.06% | -0.85% | -1.40% | 0.17% | 0.28% | Upgrade |
EPS (Basic) | 8.00 | 7.67 | 3.28 | 3.94 | 3.97 | 2.51 | Upgrade |
EPS (Diluted) | 7.97 | 7.64 | 3.26 | 3.91 | 3.94 | 2.49 | Upgrade |
EPS Growth | 151.42% | 134.36% | -16.62% | -0.76% | 58.23% | 20.87% | Upgrade |
Free Cash Flow | 6,775 | 6,351 | 5,059 | 7,804 | 8,648 | 5,724 | Upgrade |
Free Cash Flow Growth | 6.68% | 25.54% | -35.17% | -9.76% | 51.08% | 27.26% | Upgrade |
Free Cash Flow Per Share | 3.88 | 3.63 | 2.89 | 4.42 | 4.83 | 3.20 | Upgrade |
Dividends Per Share | 2.320 | 2.240 | 2.080 | 1.920 | 1.820 | 1.530 | Upgrade |
Dividend Growth | 3.57% | 7.69% | 8.33% | 5.50% | 18.95% | 15.91% | Upgrade |
Gross Margin | 51.90% | 50.93% | 50.28% | 51.54% | 52.21% | 50.49% | Upgrade |
Operating Margin | 17.43% | 16.27% | 16.15% | 19.16% | 19.56% | 15.48% | Upgrade |
Profit Margin | 32.43% | 31.95% | 14.27% | 15.88% | 16.42% | 12.92% | Upgrade |
FCF Margin | 15.72% | 15.14% | 12.61% | 17.88% | 20.08% | 16.54% | Upgrade |
EBITDA | 10,656 | 10,043 | 9,721 | 11,629 | 11,963 | 8,684 | Upgrade |
EBITDA Margin | 24.72% | 23.94% | 24.24% | 26.64% | 27.77% | 25.09% | Upgrade |
EBIT | 7,515 | 6,825 | 6,478 | 8,362 | 8,425 | 5,357 | Upgrade |
EBIT Margin | 17.43% | 16.27% | 16.15% | 19.16% | 19.56% | 15.48% | Upgrade |
Effective Tax Rate | -76.99% | -91.10% | 14.12% | 16.53% | 13.88% | 10.00% | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.